Not too much new in the quarterly.
aev well undervalued when you consider the following
baobab financially very attractive and company very bullish on being able to fund expansion. Mine life of 13 yrs is only on indicated reserve of 42m tonnes so NPV would be much higher if company converted inferred resource of 320m tonnes.
novaphos technology commercially viable, this is a total gamechanger that the market hasn’t cottoned onto yet.
scoping study on wonarah using novaphos tech will produce extremely robust financials and will open up new Australian phosphate frontier in the NT.
from here on in we should see avenira deliver on some of its promise.
- Forums
- ASX - By Stock
- AEV
- Ann: Quarterly Activities Report
Ann: Quarterly Activities Report, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AEV (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.9¢ |
Change
-0.001(5.26%) |
Mkt cap ! $25.68M |
Open | High | Low | Value | Volume |
0.9¢ | 0.9¢ | 0.9¢ | $3.752K | 416.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2796798 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 300000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2796798 | 0.009 |
7 | 720000 | 0.008 |
4 | 1442142 | 0.007 |
8 | 21007328 | 0.006 |
2 | 1500001 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 300000 | 1 |
0.011 | 1783566 | 5 |
0.012 | 659923 | 6 |
0.013 | 152257 | 2 |
0.014 | 2440000 | 5 |
Last trade - 13.54pm 12/11/2024 (20 minute delay) ? |
Featured News
AEV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online